Search research articles
Contact Us
Filters
Showing results (11-20 of 165) with videos related to
Page
of 17
Sort By:
Cold Spring Harbor Perspectives in Medicine
|
August 28, 2019
Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)
Kelly Mitchell, Ulrich Steidl
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2019
Aurora Kinase A Inhibition: A Mega-Hit for Myelofibrosis Therapy?
Richard T Piszczatowski, Ulrich Steidl
Blood
|
July 5, 2014
CDK6, a new target in MLL-driven leukemia
Iléana Antony-Debré, Ulrich Steidl
Cancer Discovery
|
April 6, 2016
Molecular Mechanism of Mutant CALR-Mediated Transformation
Robert F Stanley, Ulrich Steidl
Blood
|
February 3, 2022
Posttranscriptional Arid3a deregulation in AMKL
Justin C Wheat, Ulrich Steidl
Cell Stem Cell
|
July 9, 2016
Eliminating Cancer Stem Cells in CML with Combination Transcriptional Therapy
Luis A Carvajal, Ulrich Steidl
Cancer Cell
|
March 16, 2017
ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network
Justin C Wheat, Ulrich Steidl
Cancer Cell
|
May 13, 2015
Functionally relevant RNA helicase mutations in familial and sporadic myeloid malignancies
Iléana Antony-Debré, Ulrich Steidl
Blood
|
August 26, 2021
Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia
Justin C Wheat, Ulrich Steidl
Blood
|
March 26, 2016
Ectopic DNMT3B expression delays leukemogenesis
Robert F Stanley, Ulrich Steidl
Page
of 17
Search research articles
Search
Showing results (11-20 of 165) with videos related to
Sort By:
Page
of 17
Cold Spring Harbor Perspectives in Medicine
|
August 28, 2019
Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)
Kelly Mitchell, Ulrich Steidl
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2019
Aurora Kinase A Inhibition: A Mega-Hit for Myelofibrosis Therapy?
Richard T Piszczatowski, Ulrich Steidl
Blood
|
July 5, 2014
CDK6, a new target in MLL-driven leukemia
Iléana Antony-Debré, Ulrich Steidl
Cancer Discovery
|
April 6, 2016
Molecular Mechanism of Mutant CALR-Mediated Transformation
Robert F Stanley, Ulrich Steidl
Blood
|
February 3, 2022
Posttranscriptional Arid3a deregulation in AMKL
Justin C Wheat, Ulrich Steidl
Cell Stem Cell
|
July 9, 2016
Eliminating Cancer Stem Cells in CML with Combination Transcriptional Therapy
Luis A Carvajal, Ulrich Steidl
Cancer Cell
|
March 16, 2017
ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network
Justin C Wheat, Ulrich Steidl
Cancer Cell
|
May 13, 2015
Functionally relevant RNA helicase mutations in familial and sporadic myeloid malignancies
Iléana Antony-Debré, Ulrich Steidl
Blood
|
August 26, 2021
Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia
Justin C Wheat, Ulrich Steidl
Blood
|
March 26, 2016
Ectopic DNMT3B expression delays leukemogenesis
Robert F Stanley, Ulrich Steidl
Page
of 17